AbbVie (ABBV) Increases Buyback by $5B

The board of directors of AbbVie Inc. (NYSE: ABBV) has authorized a $5 billion increase to AbbVie's existing stock repurchase program.

Purchases may be made from time to time in management's discretion. The stock repurchase authorization permits shares to be repurchased in open market or private transactions, has no time limit and may be discontinued at any time.

You May Also Be Interested In

• Ohio Valley Banc Corp. extends stock buyback program to August 2027
• A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
• Abbvie (ABBV) PT Raised to $300 at Wells Fargo